Kaul A - Search Results

1

A replicon-based bioassay for the measurement of interferons in patients with chronic hepatitis C.

Vrolijk JM, Kaul A, Hansen BE, Lohmann V, Haagmans BL, Schalm SW, Bartenschlager R. Vrolijk JM, et al. Among authors: kaul a. J Virol Methods. 2003 Jun 30;110(2):201-9. doi: 10.1016/s0166-0934(03)00134-4. J Virol Methods. 2003. PMID: 12798249 Clinical Trial.

2

Replication of the hepatitis C virus in cell culture.

Bartenschlager R, Kaul A, Sparacio S. Bartenschlager R, et al. Among authors: kaul a. Antiviral Res. 2003 Oct;60(2):91-102. doi: 10.1016/j.antiviral.2003.08.016. Antiviral Res. 2003. PMID: 14638404 Review.

3

Persistent and transient replication of full-length hepatitis C virus genomes in cell culture.

Pietschmann T, Lohmann V, Kaul A, Krieger N, Rinck G, Rutter G, Strand D, Bartenschlager R. Pietschmann T, et al. Among authors: kaul a. J Virol. 2002 Apr;76(8):4008-21. doi: 10.1128/jvi.76.8.4008-4021.2002. J Virol. 2002. PMID: 11907240 Free PMC article.

4

Hepatitis C virus RNA replication is resistant to tumour necrosis factor-alpha.

Frese M, Barth K, Kaul A, Lohmann V, Schwärzle V, Bartenschlager R. Frese M, et al. Among authors: kaul a. J Gen Virol. 2003 May;84(Pt 5):1253-1259. doi: 10.1099/vir.0.18997-0. J Gen Virol. 2003. PMID: 12692291

5

Dissecting the interferon-induced inhibition of hepatitis C virus replication by using a novel host cell line.

Windisch MP, Frese M, Kaul A, Trippler M, Lohmann V, Bartenschlager R. Windisch MP, et al. Among authors: kaul a. J Virol. 2005 Nov;79(21):13778-93. doi: 10.1128/JVI.79.21.13778-13793.2005. J Virol. 2005. PMID: 16227297 Free PMC article.

6

Characterization of the early steps of hepatitis C virus infection by using luciferase reporter viruses.

Koutsoudakis G, Kaul A, Steinmann E, Kallis S, Lohmann V, Pietschmann T, Bartenschlager R. Koutsoudakis G, et al. Among authors: kaul a. J Virol. 2006 Jun;80(11):5308-20. doi: 10.1128/JVI.02460-05. J Virol. 2006. PMID: 16699011 Free PMC article.

7

The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro.

Paeshuyse J, Kaul A, De Clercq E, Rosenwirth B, Dumont JM, Scalfaro P, Bartenschlager R, Neyts J. Paeshuyse J, et al. Among authors: kaul a. Hepatology. 2006 Apr;43(4):761-70. doi: 10.1002/hep.21102. Hepatology. 2006. PMID: 16557546 Free article.

8

Adaptation of the hepatitis C virus to cell culture.

Kaul A, Wörz I, Bartenschlager R. Kaul A, et al. Methods Mol Biol. 2009;510:361-72. doi: 10.1007/978-1-59745-394-3_27. Methods Mol Biol. 2009. PMID: 19009275

9

Essential role of cyclophilin A for hepatitis C virus replication and virus production and possible link to polyprotein cleavage kinetics.

Kaul A, Stauffer S, Berger C, Pertel T, Schmitt J, Kallis S, Zayas M, Lohmann V, Luban J, Bartenschlager R. Kaul A, et al. PLoS Pathog. 2009 Aug;5(8):e1000546. doi: 10.1371/journal.ppat.1000546. Epub 2009 Aug 14. PLoS Pathog. 2009. PMID: 19680534 Free PMC article.

10

Identification of type I and type II interferon-induced effectors controlling hepatitis C virus replication.

Metz P, Dazert E, Ruggieri A, Mazur J, Kaderali L, Kaul A, Zeuge U, Windisch MP, Trippler M, Lohmann V, Binder M, Frese M, Bartenschlager R. Metz P, et al. Among authors: kaul a. Hepatology. 2012 Dec;56(6):2082-93. doi: 10.1002/hep.25908. Epub 2012 Oct 14. Hepatology. 2012. PMID: 22711689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

901 results

Search Page

Filters